A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial(1)

BACKGROUND: Safinamide modulates both dopaminergic and glutamatergic systems with positive effects on motor and non-motor symptoms of Parkinson’s disease (PD). The drug utilization study SYNAPSES was designed to investigate the use of safinamide in routine clinical practice, as recommended by the Eu...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbruzzese, Giovanni, Kulisevsky, Jaime, Bergmans, Bruno, Gomez-Esteban, Juan C., Kägi, Georg, Raw, Jason, Stefani, Alessandro, Warnecke, Tobias, Jost, Wolfgang H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990425/
https://www.ncbi.nlm.nih.gov/pubmed/33104040
http://dx.doi.org/10.3233/JPD-202224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990425/
https://www.ncbi.nlm.nih.gov/pubmed/33104040
http://dx.doi.org/10.3233/JPD-202224

Ejemplares similares